CN Stock MarketDetailed Quotes

301230 PharmaResources

Watchlist
  • 19.86
  • +0.09+0.46%
Market Closed Sep 10 15:00 CST
2.77BMarket Cap134.19P/E (TTM)

PharmaResources Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Total operating revenue
11.83%265.76M
7.69%130.73M
2.26%489.72M
10.56%367.21M
15.44%237.66M
16.37%121.39M
6.84%478.88M
12.58%332.13M
8.67%205.87M
33.00%104.31M
Operating revenue
11.83%265.76M
7.69%130.73M
2.26%489.72M
10.56%367.21M
15.44%237.66M
16.37%121.39M
6.84%478.88M
12.58%332.13M
8.67%205.87M
33.00%104.31M
Other operating revenue
-25.44%6.37M
----
36.64%9.24M
----
427.56%8.54M
----
281.02%6.76M
----
170.43%1.62M
----
Total operating cost
32.21%264.86M
29.49%135.33M
9.94%450.09M
9.86%319.39M
9.98%200.33M
13.03%104.5M
13.31%409.4M
18.30%290.74M
14.36%182.15M
92.46M
Operating cost
35.64%202.57M
33.19%103.78M
11.98%338.51M
13.20%240.12M
16.60%149.34M
17.16%77.92M
10.00%302.3M
12.96%212.12M
4.75%128.08M
45.40%66.5M
Operating tax surcharges
43.74%797.96K
66.97%521.75K
-25.27%1.24M
-26.84%915.16K
-28.30%555.13K
-23.49%312.47K
-5.98%1.66M
-8.49%1.25M
-26.63%774.29K
--408.41K
Operating expense
23.93%6.84M
24.22%3.18M
58.85%12.9M
76.95%8.89M
104.56%5.52M
68.35%2.56M
54.88%8.12M
44.02%5.02M
15.41%2.7M
26.00%1.52M
Administration expense
10.05%31.72M
21.04%16.11M
-15.77%60.69M
-22.93%43.89M
-29.25%28.82M
-6.91%13.31M
24.76%72.05M
35.99%56.94M
51.36%40.74M
17.60%14.3M
Financial expense
103.51%111.85K
92.84%454.45K
92.08%-584.6K
55.44%-3.14M
22.33%-3.19M
-86.52%235.67K
-260.10%-7.38M
-494.75%-7.05M
-449.20%-4.11M
232.99%1.75M
-Interest expense (Financial expense)
134.01%4.75M
130.56%2.41M
13.97%5.46M
-19.27%2.94M
-17.18%2.03M
-17.27%1.05M
89.29%4.79M
134.62%3.64M
252.33%2.45M
--1.26M
-Interest Income (Financial expense)
48.18%-1.82M
76.32%-724.22K
-91.64%-5.53M
-857.76%-4.16M
-1,698.18%-3.52M
-4,030.13%-3.06M
-366.43%-2.88M
21.85%-434.71K
59.90%-195.68K
---74.05K
Research and development
18.33%22.82M
10.93%11.27M
14.34%37.34M
27.95%28.72M
38.04%19.28M
27.44%10.16M
90.46%32.65M
137.38%22.45M
152.52%13.97M
259.99%7.97M
Credit Impairment Loss
-239.30%-1.4M
-1,289.62%-795.77K
-208.10%-273.14K
-146.85%-151.34K
496.16%1.01M
-89.10%66.89K
110.25%252.66K
120.15%323.02K
109.33%168.73K
--613.63K
Asset Impairment Loss
233.95%2.69M
338.62%3.26M
-458.93%-12.09M
-50.42%-2.41M
3.98%-2.01M
12.55%-1.37M
-4.98%-2.16M
30.41%-1.6M
7.44%-2.09M
---1.56M
Other net revenue
1,826.45%9.59M
1,226.30%6.36M
-164.76%-2.18M
167.16%1.67M
-25.57%-555.47K
323.51%479.89K
1,580.07%3.37M
134.37%625.16K
86.75%-442.35K
-214.71K
Fair value change income
106.16%184.02K
32.56%1.19M
5,716.89%5.58M
1,568.97%2.36M
-1,110.18%-2.99M
327.83%901.4K
-124.98%-99.35K
-127.40%-160.46K
-156.39%-246.76K
---395.65K
Invest income
76.69%5.33M
320.44%1.94M
4.17%628.46K
21.08%726.01K
539.55%3.02M
1.50%461.08K
-66.52%603.32K
32.29%599.62K
57,745.02%471.45K
--454.25K
-Including: Investment income associates
----
----
----
----
----
----
101.78%28.89
----
189.50%732.01
---597.33
Asset deal income
----
----
--5.8K
--5.8K
--3.02K
--3.02K
----
----
----
----
Other revenue
569.38%2.79M
85.95%768.29K
-16.79%3.97M
-22.12%1.14M
-66.88%416.43K
-38.76%413.17K
132.52%4.77M
40.07%1.46M
328.12%1.26M
--674.63K
Operating profit
-71.45%10.5M
-89.84%1.76M
-48.60%37.44M
17.79%49.49M
58.00%36.77M
49.19%17.37M
-15.95%72.85M
-11.40%42.02M
-13.20%23.27M
-14.34%11.64M
Add:Non operating Income
1,731.40%123.62K
1,877.39%121.61K
-87.22%26.28K
-96.72%6.75K
-91.65%6.75K
-91.89%6.15K
261.55%205.67K
884.73%205.67K
334.85%80.88K
--75.83K
Less:Non operating expense
-81.27%52.36K
-79.24%28.45K
446.89%707.82K
579.52%502.02K
414.69%279.58K
743.74%137.02K
-73.52%129.43K
-53.86%73.88K
-41.42%54.32K
--16.24K
Total profit
-71.04%10.57M
-89.22%1.86M
-49.59%36.76M
16.25%49M
56.65%36.5M
47.31%17.24M
-15.44%72.92M
-10.86%42.15M
-12.86%23.3M
-13.53%11.7M
Less:Income tax cost
-249.77%-5.41M
-192.27%-1.81M
-114.91%-856.47K
-22.92%3.07M
29.93%3.61M
49.51%1.96M
-54.60%5.75M
-44.92%3.98M
-34.82%2.78M
--1.31M
Net profit
-51.42%15.98M
-75.99%3.67M
-44.00%37.62M
20.33%45.93M
60.26%32.89M
47.03%15.28M
-8.70%67.18M
-4.72%38.17M
-8.70%20.52M
-6.81%10.39M
Net profit from continuing operation
-51.42%15.98M
-75.99%3.67M
-44.00%37.62M
20.33%45.93M
60.26%32.89M
47.03%15.28M
-8.70%67.18M
-4.72%38.17M
-8.70%20.52M
--10.39M
Net profit of parent company owners
-51.42%15.98M
-75.99%3.67M
-44.00%37.62M
20.33%45.93M
60.26%32.89M
47.03%15.28M
-8.70%67.18M
-4.72%38.17M
-8.70%20.52M
-6.81%10.39M
Earning per share
Basic earning per share
-54.17%0.11
-78.57%0.03
-55.70%0.35
-9.46%0.4268
-7.69%0.24
-22.22%0.14
-38.28%0.79
-32.66%0.4714
-33.33%0.26
--0.18
Diluted earning per share
-54.17%0.11
-78.57%0.03
-55.70%0.35
-9.46%0.4268
-7.69%0.24
-22.22%0.14
-38.28%0.79
-32.66%0.4714
-33.33%0.26
--0.18
Other composite income
-162.94%-51.9K
371.96%82.46K
250.87%69.91K
161.81%82.46K
62.30%82.46K
-112.84%-30.32K
157.91%19.92K
161.03%31.5K
50.81K
Other composite income of parent company owners
-162.94%-51.9K
----
371.96%82.46K
250.87%69.91K
161.81%82.46K
62.30%82.46K
-112.84%-30.32K
157.91%19.92K
161.03%31.5K
--50.81K
Total composite income
-51.70%15.92M
-76.12%3.67M
-43.85%37.7M
20.45%46M
60.42%32.97M
47.10%15.36M
-9.03%67.15M
-4.59%38.19M
-8.35%20.55M
10.44M
Total composite income of parent company owners
-51.70%15.92M
-76.12%3.67M
-43.85%37.7M
20.45%46M
60.42%32.97M
47.10%15.36M
-9.03%67.15M
-4.59%38.19M
-8.35%20.55M
--10.44M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
Lixin Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Total operating revenue 11.83%265.76M7.69%130.73M2.26%489.72M10.56%367.21M15.44%237.66M16.37%121.39M6.84%478.88M12.58%332.13M8.67%205.87M33.00%104.31M
Operating revenue 11.83%265.76M7.69%130.73M2.26%489.72M10.56%367.21M15.44%237.66M16.37%121.39M6.84%478.88M12.58%332.13M8.67%205.87M33.00%104.31M
Other operating revenue -25.44%6.37M----36.64%9.24M----427.56%8.54M----281.02%6.76M----170.43%1.62M----
Total operating cost 32.21%264.86M29.49%135.33M9.94%450.09M9.86%319.39M9.98%200.33M13.03%104.5M13.31%409.4M18.30%290.74M14.36%182.15M92.46M
Operating cost 35.64%202.57M33.19%103.78M11.98%338.51M13.20%240.12M16.60%149.34M17.16%77.92M10.00%302.3M12.96%212.12M4.75%128.08M45.40%66.5M
Operating tax surcharges 43.74%797.96K66.97%521.75K-25.27%1.24M-26.84%915.16K-28.30%555.13K-23.49%312.47K-5.98%1.66M-8.49%1.25M-26.63%774.29K--408.41K
Operating expense 23.93%6.84M24.22%3.18M58.85%12.9M76.95%8.89M104.56%5.52M68.35%2.56M54.88%8.12M44.02%5.02M15.41%2.7M26.00%1.52M
Administration expense 10.05%31.72M21.04%16.11M-15.77%60.69M-22.93%43.89M-29.25%28.82M-6.91%13.31M24.76%72.05M35.99%56.94M51.36%40.74M17.60%14.3M
Financial expense 103.51%111.85K92.84%454.45K92.08%-584.6K55.44%-3.14M22.33%-3.19M-86.52%235.67K-260.10%-7.38M-494.75%-7.05M-449.20%-4.11M232.99%1.75M
-Interest expense (Financial expense) 134.01%4.75M130.56%2.41M13.97%5.46M-19.27%2.94M-17.18%2.03M-17.27%1.05M89.29%4.79M134.62%3.64M252.33%2.45M--1.26M
-Interest Income (Financial expense) 48.18%-1.82M76.32%-724.22K-91.64%-5.53M-857.76%-4.16M-1,698.18%-3.52M-4,030.13%-3.06M-366.43%-2.88M21.85%-434.71K59.90%-195.68K---74.05K
Research and development 18.33%22.82M10.93%11.27M14.34%37.34M27.95%28.72M38.04%19.28M27.44%10.16M90.46%32.65M137.38%22.45M152.52%13.97M259.99%7.97M
Credit Impairment Loss -239.30%-1.4M-1,289.62%-795.77K-208.10%-273.14K-146.85%-151.34K496.16%1.01M-89.10%66.89K110.25%252.66K120.15%323.02K109.33%168.73K--613.63K
Asset Impairment Loss 233.95%2.69M338.62%3.26M-458.93%-12.09M-50.42%-2.41M3.98%-2.01M12.55%-1.37M-4.98%-2.16M30.41%-1.6M7.44%-2.09M---1.56M
Other net revenue 1,826.45%9.59M1,226.30%6.36M-164.76%-2.18M167.16%1.67M-25.57%-555.47K323.51%479.89K1,580.07%3.37M134.37%625.16K86.75%-442.35K-214.71K
Fair value change income 106.16%184.02K32.56%1.19M5,716.89%5.58M1,568.97%2.36M-1,110.18%-2.99M327.83%901.4K-124.98%-99.35K-127.40%-160.46K-156.39%-246.76K---395.65K
Invest income 76.69%5.33M320.44%1.94M4.17%628.46K21.08%726.01K539.55%3.02M1.50%461.08K-66.52%603.32K32.29%599.62K57,745.02%471.45K--454.25K
-Including: Investment income associates ------------------------101.78%28.89----189.50%732.01---597.33
Asset deal income ----------5.8K--5.8K--3.02K--3.02K----------------
Other revenue 569.38%2.79M85.95%768.29K-16.79%3.97M-22.12%1.14M-66.88%416.43K-38.76%413.17K132.52%4.77M40.07%1.46M328.12%1.26M--674.63K
Operating profit -71.45%10.5M-89.84%1.76M-48.60%37.44M17.79%49.49M58.00%36.77M49.19%17.37M-15.95%72.85M-11.40%42.02M-13.20%23.27M-14.34%11.64M
Add:Non operating Income 1,731.40%123.62K1,877.39%121.61K-87.22%26.28K-96.72%6.75K-91.65%6.75K-91.89%6.15K261.55%205.67K884.73%205.67K334.85%80.88K--75.83K
Less:Non operating expense -81.27%52.36K-79.24%28.45K446.89%707.82K579.52%502.02K414.69%279.58K743.74%137.02K-73.52%129.43K-53.86%73.88K-41.42%54.32K--16.24K
Total profit -71.04%10.57M-89.22%1.86M-49.59%36.76M16.25%49M56.65%36.5M47.31%17.24M-15.44%72.92M-10.86%42.15M-12.86%23.3M-13.53%11.7M
Less:Income tax cost -249.77%-5.41M-192.27%-1.81M-114.91%-856.47K-22.92%3.07M29.93%3.61M49.51%1.96M-54.60%5.75M-44.92%3.98M-34.82%2.78M--1.31M
Net profit -51.42%15.98M-75.99%3.67M-44.00%37.62M20.33%45.93M60.26%32.89M47.03%15.28M-8.70%67.18M-4.72%38.17M-8.70%20.52M-6.81%10.39M
Net profit from continuing operation -51.42%15.98M-75.99%3.67M-44.00%37.62M20.33%45.93M60.26%32.89M47.03%15.28M-8.70%67.18M-4.72%38.17M-8.70%20.52M--10.39M
Net profit of parent company owners -51.42%15.98M-75.99%3.67M-44.00%37.62M20.33%45.93M60.26%32.89M47.03%15.28M-8.70%67.18M-4.72%38.17M-8.70%20.52M-6.81%10.39M
Earning per share
Basic earning per share -54.17%0.11-78.57%0.03-55.70%0.35-9.46%0.4268-7.69%0.24-22.22%0.14-38.28%0.79-32.66%0.4714-33.33%0.26--0.18
Diluted earning per share -54.17%0.11-78.57%0.03-55.70%0.35-9.46%0.4268-7.69%0.24-22.22%0.14-38.28%0.79-32.66%0.4714-33.33%0.26--0.18
Other composite income -162.94%-51.9K371.96%82.46K250.87%69.91K161.81%82.46K62.30%82.46K-112.84%-30.32K157.91%19.92K161.03%31.5K50.81K
Other composite income of parent company owners -162.94%-51.9K----371.96%82.46K250.87%69.91K161.81%82.46K62.30%82.46K-112.84%-30.32K157.91%19.92K161.03%31.5K--50.81K
Total composite income -51.70%15.92M-76.12%3.67M-43.85%37.7M20.45%46M60.42%32.97M47.10%15.36M-9.03%67.15M-4.59%38.19M-8.35%20.55M10.44M
Total composite income of parent company owners -51.70%15.92M-76.12%3.67M-43.85%37.7M20.45%46M60.42%32.97M47.10%15.36M-9.03%67.15M-4.59%38.19M-8.35%20.55M--10.44M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Lixin Certified Public Accountants (Special General Partnership)------Lixin Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg